Dr. Girijesh Kumar Patel


Dr. Girijesh Kumar Patel

Assistant Professor
Department of Biotechnology
Motilal Nehru National Institute of Technology Allahabad, Prayagraj, India-211004
E-mail: gkpatel[at]mnnit[dot]ac[dot]in
Telephone: +91-532-227-1231(O) +91-945-070-6922(M)

Research Publications


Books:

Babu V., Thapliyal A. and Patel G.K. (Eds.) (2013) “Biofuels Production” ISBN: 978-11-1863-450-9 Scrivener Publishing-Wiley, 1303 Chestnut, Ave, Austin, TX-78702.

Book Chapter:

1. Shahi A., Patel G.K.*., Kumar S., Singh M., Varshney A., Ghoshal U.C*. (2024) Production and therapeutic applications of monoclonal antibodies in cancer and other diseases. In Microbial Enzymes, Production, Innovations and Applications. Yadav D., Chowdhary P. Anand G. and Gaur R.K. (Eds). ISBN: 978-35-273-52906, John Wiley & Sons Australia Lt, (In Press) *Corresponding Author
2. Soni V.K. Amit A., Chandra V., Singh P., Singh P.K., Singh R.P., Patel G.K., Singh R.P. (2022) Role of food additives and intestinal microflora in colorectal cancer. In: Shukla D., Vishvakarma N.K., Nagaraju G.P. (Eds.) Colon Cancer Diagnosis and Therapy Vol. 3. Springer, Cham. pp. 23-49. ISBN: 978-3-030-72701-7
3. Khan M.A., Patel G.K., Zubair H., Tyagi N., Azim S., Singh, S., Ahmad A., Singh A.P. (2020) Nuclear factor kappa-β: bridging inflammation and cancer, in: Signaling in Cancer, Batra S.K., Ponnusamy M.P. (Eds.) Vol. 10. Taylor & Francis Group-CRC Press. pp. 23-49. ISBN: 978-13-1520-019-4.
4. Patel G.K.*, Goyal R., Waheed S.M. (2019) Current update on rapamycin production and its potential clinical implications. In: high-value fermentation products Volume 1. Saran S., Babu V. Chaubey A. (Eds). pp.145-160. Scrivener Publishing-Wiley ISBN: 978-11-1946-001-5 *Corresponding Author.
5. Patel G.K., Zubair H., Khan M.A., Srivastava S.K., Ahmad A., Patton M.C., Singh S., Khushman M., Singh A.P. (2018) Exosomes: Key supporters of metastasis, In: Exosomes in cancer: diagnostic, pharmaceutical, and therapeutic applications, M.M. Amiji and R. Rajagopal (Eds.). pp 261-283. Academic Press, Elsevier. ISBN: 978-01-2812-774.
6. Zubair H., Azim, S., Khan M. A., Patel G.K. Singh S., Singh A.P. (2018) Epigenetic control of pancreatic carcinogenesis and its regulation by natural products. In: Epigenetics of Chemoprevention, Bishayee, A. and Bhatia D. (Eds), pp. 251-270. Academic Press, Elsevier. ISBN:978-01-2812-566.
7. Goyal R., Babu V. Patel G.K*. (2013) Biomethane Production In: “Biofuels Production” Babu V., Thapliyal A. and Patel G.K. (Eds.) Scrivener Publishing-Wiley, pp-333-356. ISBN:978-11-1863-450-9 *Corresponding Author.
8. Saxena K., Aseri G.K., Patel G.K., Babu V. (2013) Molecular biology of nitrile metabolizing enzymes In: Molecular Biology of Bacteria. Gaur R.K., Gautam H.K. (Eds.) Nova Science Publisher, pp 31-53, ISBN: 978-16-2618-189-2.

Journals:

1. Patel G.K.*, Verma S.K., Misra S., Chand G., Rao, R.N. (2023) Molecular drivers of prostate cancer pathogenesis and therapy resistance. Frontiers in Cell and Developmental Biology, 11:1-3 doi:10.3389/fcell.2023.1239478. *Corresponding author.
2. Dutta S., Patel G.K., Khedmatgozar H., Tripathi M., Nandana S. (2023) TBX2 driven switch from androgen receptor to glucocorticoid receptor signaling confers therapeutic resistance in prostate cancer. bioRxiv 2023.05.07.539754; doi: 10.1101/2023.05.07.539754.
3. Verma P., Shukla N., Kumari S., Ansari M.S., Gautam N.K., Patel G.K.* (2023) Cancer stem cell in prostate cancer progression, metastasis and therapy resistance. BBA: Review on Cancer, 1878(3), 188887. *Corresponding author.
4. Srivastava S.K., Khan M.A., Zubair H., Anand S., Deshmukh S.K., Patel G.K., Singh S., Andrew J. Wang B., Carter J.E., Singh A.P. (2022) MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer. British Journal of Cancer, 126(8):1205-1214.
5. Patel G.K., Dutta S., Syed M.M., Ramachandran S., Sharma M., Rajamanickam V., Ganapathy V., DeGraff D.J., Pruitt K.,Tripathi M., Nandana S. (2021) TBX2 drives neuroendocrine prostate cancer through exosome-mediated repression of miR-200c-3p. Cancers, 13(19), 5020.
6. Kumar S., Patel G.K., Ghoshal U.C. (2021) Helicobacter pylori-induced inflammation: Possible factors modulating the risk of gastric cancer. Pathogens, 10(9), 1099.
7. Khushman M., Prodduturvar P., Mneimneh W., Zotto V.D., Akbar S., Grimm L., Rider P., Hunter J., Alkharabsheh O., Patel G.K., Fabregas J., Singh A.P. (2021) The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma. Oncotarget, 12:1490-1498.
8. Khushman M., Patel G.K., Maharjan A.S., McMillin G.A., Nelson C., Wang B., Hosein P., Singh A. P. (2021). The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy. The Pharmacogenomics Journal, 21(3):308–317
9. Patel G.K.*, Zubair H.*, Khan M.A., Shafquat A., Zubair A., Singh S., Srivastava S.K., Singh A.P. (2020) Proteomic analysis of MYB-regulated secretome identifies functional pathways and biomarkers: potential pathobiological and clinical implications. Journal of Proteome Research, 19 (2):794−804. *Shared first Author.
10. Khan M.A., Srivastava S.K., Zubair H., Patel G.K., Arora S., Khushman M., Carter J.E., Gorman G.S., Singh S., Singh A.P. (2020) Co-targeting of CXCR4 and hedgehog pathways disrupts tumor–stromal cross-talk and improves chemotherapeutic efficacy in a mouse model of pancreatic cancer. Journal of Biological Chemistry, 295(25):8413-8424.
11. Patel G.K., Perry J., Abdul-Rahim O., Frankel A.E., Cameron D. Taylor W.R., Rocconi R.P., Khushman M. Nelson C., Singh A.P. (2020) EGFR activating E746_T751>VP mutation (E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by EGFR A647T-mediated resistance: A case report and literature review. Journal of Cancer Research and Therapeutics, 16(4):950-954.
12. Patel G.K., Chugh N., Tripathi M. (2019) Neuroendocrine differentiation of prostate cancer - An intriguing example of tumor evolution at play. Cancers, 11(10): 1405.
13. Kanchanapally R., Deshmukh S.K., Chavva S.R., Tyagi N., Srivastava S.K., Patel G.K., Singh A.P., Singh S (2019) Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. International Journal of Nanomedicine, 14: 531-541.
14. Patel G.K., Khan M.A., Zubair H., Srivastava S.K., Patton M.C., Singh S., Khushman M., Singh A.P. (2019) Comparative analysis of exosome isolation methods for optimum yield, purity and downstream applications, Scientific Reports, 9(1):5335
15. Maharjan A.S., McMillin G.A., Patel G.K., Awan S., Taylor, W.R., Pai, S., Frankel A.E., Nelson C., Wang B., Hosein, P.J., Singh A.P., Khushman M. (2019) The prevalence of DPYD*9A (c.85T>C) genotype and the genotype-phenotype correlation in patients with gastrointestinal malignancies treated with fluoropyrimidines: Updated analysis. Clinical Colorectal Cancer, 18(3): e280-e286.
16. Khushman M., Patel G.K., Laurini J.A., Bhardwaj A., Roveda K., Donnell R, et al. (2019) Exosomal Markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry (IHC) in patients with pancreatic ductal adenocarcinoma (PDAC). Journal of Gastrointestinal Oncology, 10(4):695-702.
17. Patel G.K., Khushman M., Singh S., Taylor W.R., Singh A.P (2018) Revisiting the Clinical importance of DPYD*9A (c.85T>C) variant of dihydropyrimidine dehydrogenase (DPYD) gene in patients treated with fluoropyrimidine-based chemotherapy. Journal of Molecular Biomarkers & Diagnosis, 9(3), 1000394.
18. Khushman, M., Patel G.K., Hosein, P.J, Laurini, J.A., Cameron D., Clarkson D.R., Butler T.W., Norden C.W., Baliem J., Wilma V., Bhadkamkar S., Nelson C., Lee F., Singh A.P., Taylor W.R. (2018) Germline pharmacogenomics of dihydropyrimidine dehydrogenase (DPD) enzyme in patients with gastrointestinal (GI) malignancies treated with fluoropyrimidines. Journal of Gastrointestinal Oncology, 9(3) 416-424.
19. Khan M.A., Patel G.K., Srivastava S.K., Singh S., and Singh A.P. (2018) Looking at cancer health disparities without the colored lenses. Cancer Health Disparities, 2: e1-e9.
20. Patel G.K., Khan M.A., Bhardwaj A., Srivastava S.K., Zubair H., Patton M.C., Singh S., Khushman M., Singh A.P. (2017) Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS-detoxification and miR-155-mediated suppression of key gemcitabine-metabolizing enzyme, DCK. British Journal of Cancer, 116: 609–619.
21. Khushman M., Bhardwaj A., Patel G.K., Laurini J.A., Roveda K., Tan M., Patton M.C., Singh S., Taylor W., Singh A.P. (2017) Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry (IHC) in resected malignant and non-malignant pancreatic specimens. Pancreas, 46(6): 782-788.
22. Zubair H., Bhardwaj A., Ahmad A, Khan M.A., Srivastava S.K., Patel G.K., Singh S., Sing A.P. (2017) Hydroxytyrosol induces apoptosis, cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells. Nutrition and Cancer, 69 (6): 1-11.
23. Srivastava SK., Ahmad A., Miree O., Patel G.K., Singh S., Rocconi RP., Scalici J., and Singh AP. (2017) Racial health disparities in ovarian cancer: not just black and white. J. Ovarian Research,10:58.
24. Zubair H., Azim S., Srivastava S.K., Ahmad A, Bhardwaj A., Khan M.A., Patel G.K., Sumit Arora, Carter J.E., Singh S., Singh A.P. (2016). Glucose metabolism reprogrammed by overexpression of IKK-epsilon promotes pancreatic tumor growth. Cancer Research, 76(24):7254-7264.
25. Khan M.A., Azim S., Zubair H., Bhardwaj A., Patel G.K., Khushman M., Singh S., Sing A.P. (2017). Molecular drivers of pancreatic cancer pathogenesis: looking inward to move forward. International Journal of Molecular Sciences, 18: 779.
26. Zubair H., Azim S., Ahmad A., Khan M.A., Patel G.K., Singh S. and Singh A.P. (2017) Cancer chemoprevention by phytochemicals: nature’s healing touch. Molecules, 22(3): 395.
27. Patel G.K., Paton M.C., Khusman M., Singh S. Singh A.P. (2016) Pancreatic cancer exosomes: shedding off for a meaningful journey. Pancreatic Disorders & Therapy, 6:2 e148.
28. Verma P., Patel G.K., Kar B., Sharma A.K. (2017) A case of neofunctionalization of a PNP protein to trypsin inhibitor by disrupting the PNP-UDP domain through an insert containing inhibitory site. Plant Science, 260: 19-30.
29. Kar B., Verma P., Patel G.K. Sharma A.K. (2017) Molecular cloning, characterization and in silico analysis of a thermostable β-glucosidase enzyme from Putranjiva roxburghii with a significant activity for cellobiose. Phytochemistry, 140:151-165.
30. Tomar P.P., Chaudhary N.S., Mishra, P., Gahloth D., Patel G.K., Selvakumar P., Sharma A.K. (2014) Purification, characterization and cloning of a 2S albumin with DNase, RNase and antifungal activities from Putranjiva roxburghi. Applied Biochemistry and Biotechnology, 174: 471–482.
31. Patel G.K., Gupta A.K., Gupta A., Mishra M., Singh P., Saxena A.K., Sharma A.K. (2013) Purification and physic-characterization of a trypsin inhibitor from Cassia absus Linn. Protein & Peptide Letter, 21:108-114.
32. Patel G.K. Kawale A.A., Sharma A.K. (2012) Purification and physicochemical characterization of a serine protease with fibrinolytic activity from latex of a medicinal herb Euphorbia hirta. Plant Physiology and Biochemistry, 52: 104-111.
33. Patel G.K., Kar B. and Sharma A.K., (2012) Characterization of a thermostable family 1 glycosyl hydrolase enzyme from Putranjiva roxburghii seeds. Applied Biochemistry and Biotechnology, 166:523–535.
34. *Patel G.K., *Tapas S., Dhindwal S. and Tomar S. (2011) In silico sequence analysis and molecular modeling of the three-dimensional structure of DAHP synthase from Pseudomonas fragi. Journal of Molecular Modeling, 17 (4): 621-631. (*Shared First Author)
35. Bali S., Patel G.K., Novy R., Vining K., Thompson A., Brown C., Holm D., Porter G., Endelman J., Sathuvalli V. (2018) Evaluation of genetic diversity among Russet potato clones and varieties from breeding programs across the United States. Plos One, 13(8): e0201415.
36. Patel G.K., Shee C., Gahloth D., Selvakumar P., Sharma A.K. (2011) Stability of Murraya koenigii miraculin-like protein in different physicochemical conditions. Medicinal Chemistry Research, 20(9) 1542-1549.

Conference Proceedings:

1. Patel G.K., Dutta S., Khedmatgozar H., Tripathi M., Nandana S. (2023) TBX2highmiR-375-3plowRBPJhigh signaling drives prostate cancer bone metastatic phenotype via exosomes. Cancer Research, 83 (2_Supplement_2): B024. https://doi.org/10.1158/1538-7445.METASTASIS22-B024
2. Dutta S., Patel G.K., Khedmatgozar H., Latour D., Tripathi M., Nandana S. (2023) TBX2 acts as a molecular switch to downregulate androgen receptor and upregulate glucocorticoid receptor signaling in castrate resistant prostate cancer. Cancer Res (2023) 83 (7_Supplement): 1445. https://doi.org/10.1158/1538-7445.AM2023-1445
3. Patel G.K., Dutta S., Khedmatgozar H., Tripathi M., Nandana S. (2022) TBX2 promotes prostate cancer bone-metastatic phenotype through exosomal microRNA-375-3p. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Research 2022;82(12_Suppl): Abstract nr 5999. https://doi.org/10.1158/1538-7445.AM2022-5999
4. Patel G.K., Dutta S., Syed M.M., Ramachandran S., Sharma M., Rajamanickam V., Ganapathy V., DeGraff D.J., Pruitt K., Tripathi M., Nandana S. (2021) TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p. Presented orally in the Society for Basic Urologic Research (SBUR) Nov 4-7, 2021, USA.
5. Khushman M., Prodduturvar P., Akbar S., Mneimneh W., Zotto V.D., Grimm L., Rider P., Hunter J., Patel G.K., Singh A.P. (2021) The effects of neoadjuvant chemoradiation on exosomal markers (CD63 and CD9) expression in patients with locally advanced rectal adenocarcinoma. Journal of Clinical Oncology, 39 (3_suppl.)Jan 15-17, 2021. DOI: 10.1200/JCO.2021.39.3_suppl.101
6. Prodduturvar P., McCormick B., Mneimneh W., Zotto V.D., Grimm L., Rider P, Hunter J, Iliff G., Smith C., Patel G.K., Pannell L., Singh S., Singh A.P., Perry J., Khushman M. (2019) Exosomal markers (CD63 and CD9) expression using immunohistochemistry (IHC) in patients with right-sided and left-sided colon cancer. Journal of Clinical Oncology, 37 (15_suppl.) e15119. In the ASCO Annual Meeting, May 31-June 4, 2019, in Chicago. DOI: 10.1200/JCO.2019.37.15_suppl.e15119
7. Maharjan A.S., McMillin G.A., Patel G.K., Awan S., Taylor W.R., Pai S., Frankel A.E., Nelson C., Wang B., Hosein P.J. Singh A.P., Khushman M. (2019). The correlation between DPYD*9A (c.85T > C) genotype and dihydropyrimidine dehydrogenase deficiency phenotype in patients with gastrointestinal malignancies treated with fluoropyrimidines: Updated analysis. Journal of Clinical Oncology. 37 (4_suppl) 544. In American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) Jan 15-17, 2021. DOI: 10.1200/JCO.2019.37.4_suppl.544
8. Maharjan A.S., McMillin G.A., Patel G.K., Khushman M. (2019) The Correlation between DPYD*9A(c.85T>C) genotype and dihydropyrimidine dehydrogenase deficiency phenotype in patients with gastrointestinal malignancies treated with fluoropyrimidines American Journal of Clinical Pathology, 152(1) S29-S30. in 54th Annual Meeting for Academy of Clinical Laboratory Physicians and Scientists May 30th to June 1st, 2019, at the Little America Hotel in Salt Lake City, Utah.
9. Patel G.K., Khan M.A., Zubair H., Srivastava S.K., Patton M.C., Singh S., Khushman M., Singh A.P. (2019) Exploring the potential of exosomes for cancer diagnosis and management: a comparative analysis of isolation methods for optimum yield, purity, and downstream applications. Cancer Research, 79(13 Suppl): Abstract nr 1991. In 110th AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, USA. https://doi.org/10.1158/1538-7445.AM2019-1991
10. Srivastava S.K., Zubair H., Patel G.K., Deshmukh S.K., Khan M.A., Andrew J. Wang B., Carter J.E., Singh S, Singh A.P. (2019) A novel MYB-AR cross-talk promoting castration-resistance in prostate cancer. Cancer Research,79(13 Suppl): Abstract nr 2609. https://doi.org/10.1158/1538-7445.AM2019-2609
11. Khan M.A., Patel G.K., Srivastava S.K., Zubair H., Singh S., Khushman M., Wang B., Singh A.P. (2019) Bi-directional cross-talk of pancreatic cancer and stellate cells, mediated through CXCR4 and hedgehog pathways, promotes chemoresistance via its effect on gemcitabine metabolism, ROS detoxification and cancer stemness. Cancer Research, 79(13 Suppl): Abstract nr 1911. https://doi.org/10.1158/1538-7445.AM2019-1911
12. Kanchanapally R., Deshmukh S.K., Chavva S.R., Tyagi N., Srivastava S.K., Patel G.K., Singh A.P., Singh S. (2019) Comparative analyses of drug-loaded exosomal preparations from different cell types reveal distinctive loading capability, yield, and anti-tumor efficacies. Cancer Research, 79 (13 Suppl): Abstract nr 992. https://doi.org/10.1158/1538-7445.AM2019-992
13. Awan S., Patel G.K., Maharajan A.S., McMillin G.A., Taylor W, Pai, S., Frankel A., Cameron D., Smith C., Grimm L., Rider P., Hunter J., Liles S., Nelson C. Wang Bin, Hosein P.J., Singh A.P., Khushman M. (2019) Germline pharmacogenomics of thymidylate synthase gene in patients with gastrointestinal malignancies treated with fluoropyrimidines-based chemotherapy regimens. Journal of Clinical Oncology 37 (4_suppl.) 545. DOI: 10.1200/JCO.2019.37.4_suppl.545
14. Khushman M., Bhardwaj A, Patel G.K., Laurini J., Roveda K., Donnell R, Sherling K., Case B., Tan M.C.B.., Thompson L.W., Nelson C., Wyatt M., Patton M., Singh S., Wang B., Taylor W.R., Singh A.P. (2018) The Prognostic significance of exosomal markers (CD63 and CD9) expression using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. Journal of Clinical Oncology, 36 (4_suppl.)342. In 2018 ASCO Symposium Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract was held on Jan. 18-20, 2018. DOI: 10.1200/JCO.2018.36.4_suppl.342
15. Khushman M., Patel G.K., Hosein P.J., Laurini J., Cameron D., Clarkson, D.R., Butler, T.W., Norden C., Baliem W., Jones V., Bhadkamkar S., Nelson C., Lee F., Singh AP., Taylor W.R. (2018) Germline Pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines. Journal of Clinical Oncology, 36(4_suppl.)598. Asco- 2018 Gastrointestinal Cancers Symposium. DOI: 10.1200/JCO.2018.36.4_suppl.598
16. Case B., Khushman M., Bhardwaj A., Patel G.K., Laurini J., Roveda K., Donnell R., Sherling K., Tan M., Thompson Lee, Nelson C., Wyatt M., Singh S., Taylor W., Singh A (2017) The relationship between metastatic status and exosomal marker (CD63) expression using immunohistochemistry (IHC) in patients with pancreatic ductal adenocarcinoma (PDAC). Annals of Oncology, 28 (suppl_3) iii74. ESMO 19th World Congress on Gastrointestinal Cancer 28 June-1 July 2017, Barcelona, Spain. https://doi.org/10.1093/annonc/mdx261.201
17. Bhardwaj A., Khushman M., Patel G.K., Laurini J.A., Roveda K., Tan M., Singh S., Taylor W., Singh A.P. (2016) The pattern of exosomal marker (CD63) expression using immunohistochemistry (IHC) in malignant and non- malignant (normal, inflammatory, and pre-malignant) ductal cells in resected pancreatic tissues. Cancer Research, 76(24 Suppl): Abstract no: A36. https://doi.org/10.1158/1538-7445.PANCA16-A36
18. Khushman M., Patel G.K., Bhardwaj A., Srivastava S.K., Khan M.A., Singh S., Brandt B., Taylor W.R., Singh A. (2016) The role of exosomes in promoting acquired resistance to gemcitabine and nanoparticle albumin-bound (NAB) paclitaxel in pancreatic ductal adenocarcinoma cells. Poster presented in ASCO Annual Meeting Chicago Illinois, June 3-7, 2016. Abstract published in Journal of Clinical Oncology, 34 (15_suppl) e23253). 3 - 7 Jun 2016. DOI: 10.1200/JCO.2016.34.15_suppl.e23253
19. Laurini J., Khushman M., Bhardwaj A., Patel G.K., Tan M., Singh S., Taylor W., Singh A.P. (2016) Exosomal markers (CD63 and CD9) expression by immunohistochemistry (IHC) in pancreatectomy specimens (PS). Virchows Archiv, 469 (Suppl 1): S86 Abstract# PS-05-022. In XXXI International Congress of the IAP and 28th Congress of the ESP 25-29 September 2016, Cologne, Germany. https://link.springer.com/content/pdf/10.1007/s00428-016-1997-7.pdf
20. Patel G.K., Bhardwaj A., Srivastava S.K., Khan M.A., Singh S., Khushman M., Singh A.P. (2016) Chemotherapy-induced exosomal secretion promotes chemoresistance in pancreatic cancer cells. Cancer Research, 2016 Jul 15;76(14 Supplement):2116.in 107th Annual Meeting of the American Association for Cancer Research; Apr 16-20; New Orleans, LA. Philadelphia.Abstract nr 2116. https://doi.org/10.1158/1538-7445.AM2016-2116
21. Patton M.C., Zubair H., Patel G.K., Singh S, Singh A.P. (2016) Exosomes from hypoxic pancreatic cancer cells confer resistance to subsequent hypoxia insult. Cancer Research, 15;76 (14_Supplement):2799. https://doi.org/10.1158/1538-7445.AM2016-2799
22. Zubair H., Azim S., Srivastava S.K., Ahmad A., Bhardwaj A., Khan M.A., Patel G.K., Arora S., Carter J.E., Singh S., Singh A.P. (2016) IKKε enhances nuclear-retention and stabilization of c-MYC to promote glycolytic-metabolism and pancreatic tumor growth. American Pancreatic Association 47th Annual Meeting, Boston, MA (October 26-29, 2016). https://miami.app.box.com/s/77b09806zwddjcck8gd8n1gdmnvkbp6j
23. Zubair H., Azim S., Srivastava S.K., Ahmad A., Bhardwaj A., Khan M.A., Patel G.K., Arora S, Carter JE, Singh S, Singh A.P. (2016) IKKε : a novel player in pancreatic cancer pathogenesis. In 18th Annual University of Alabama Birmingham Research Retreat and Research Competition, Birmingham, AL, USA (October 17).
24. Patel G.K., Khan M.A., Bhardwaj A., Srivastava S.K., Zubair H., Patton M.C., Singh S., Khushman M., Singh A.P. (2016) Gemcitabine induced tumor-cell exosomes impart acquired chemoresistance in pancreatic cancer. In 18th Annual Research Retreat at University of Alabama, Birmingham, USA (October 17, 2016).
25. Patton M.C., Zubair H., Patel G.K., Singh S., Singh A.P. (2015) Hypoxic pancreatic cancer cells offer survival benefit through extracellular mechanisms. Poster presented in 9th Annual College of Medicine Research Forum, University of South Alabama, AL USA. (December 4, 2015).
26. Patel G.K., Sharma A.K., Gupta A.K., and Saxena A.K. (2013) Studies on protease inhibitor against the protease involved in diseased conditions, an abstract submitted, and poster presented in 5th International Symposium on Current Trends in Drug Discovery Research at CSIR-CDRI Lucknow from 26-28 February 2013.
27. Goyal R., Sharma A.K. and Patel G.K. * (2013) DAHP synthase from mycobacterium: a novel target for the drug design an abstract submitted, and poster presented in 5th International Symposium on Current Trends in Drug Discovery Research at Central Drug Research Institute (CDRI) Lucknow from 26-28 February 2013.
28. Goyal R., Patel G.K. and Sharma A.K. (2012) SDS induced conformational change to enhance the glycosyl hydrolase family 1 enzyme activity, an abstract submitted, and poster presented in International Interdisciplinary Science Conference (I-ISC) on protein folding and disease at Jamia Millia Islamia, New Delhi on December 8-10, 2012.
29. Patel G.K., Sharma A.K., Gupta A.K., and Saxena A.K. (2013) Studies on protease inhibitor against the protease involved in diseased conditions, an abstract submitted, and poster presented in 5th International Symposium on Current Trends in Drug Discovery Research at CSIR-CDRI Lucknow from 26-28 February 2013.
30. Patel G.K., Sharma A.K., Gupta A.K., and Saxena A.K. (2013) Studies on protease inhibitor against the protease involved in diseased conditions, an abstract submitted, and poster presented in 5th International Symposium on Current Trends in Drug Discovery Research at CSIR-CDRI Lucknow from 26-28 February 2013.
31. Participated in the National symposium “BIOLOGIK -2012” on recent advances in medical, animal & plant biotechnology, organized by Beehive College of Advance Studies, Dehradun on March 15-16, 2012.
32. Patel G.K., Kar B. Sharma A.K. (2011) Presented poster on “Biochemical and biophysical characterization of Glycosyl Hydrolase Family 1 protein from Putranjiva roxburghii” in the 7th Asian Biophysics Association (ABA) Symposium & Annual Meeting of the Indian Biophysical Society (IBS) at AIIMS, New Delhi, Jan 30-Feb 2nd 2011.
33. Kar B., Patel G.K., Chaudhary N.S., Sharma A.K. (2011) Characterization, Cloning, Sequence Analysis and Modeling of a Trypsin Inhibitor from Putranjiva roxburghii in the 7th Asian Biophysics Association (ABA) Symposium & Annual Meeting of the Indian Biophysical Society (IBS) at AIIMS, New Delhi on 30th Jan to 2nd Feb, 2011.
34. Patel G.K., Shee C., Gahloth, D., Selvakumar P., Sharma A.K. (2010) Presented poster on “Stability of Murraya koenigii miraculin-like protein (MKMLP) in different physicochemical conditions” in the 4th International Symposium on Current Trends in Drug Discovery Research at Central Drug Research Institute (CDRI) Lucknow from 17-21st Feb, 2010.
35. Patel G.K. Srivastava A.K., Arora D.K. (2006) Presented poster on “Microbial diversity in the rhizosphere of Parthenium” in a National Symposium on Microbial Diversity and Plant Health Problems at DDU Gorakhpur University held on Dec.18-19, 2006.
36. Singh R.P., Patel G.K., Srivastava A.K., Arora D.K. (2005) Presented poster on “Herbicidal activity in metabolite produced by fungus in a National Seminar at Shri Murli Manohar Town P.G College Ballia, U.P. held on October15-17, 2005.
37. Patel G.K. Srivastava, A.K. Arora D.K. (2005) Presented paper on “Role of Microbial metabolite for the control of the Parthenium weed” in a National Seminar at Shri Murli Manohar Town P.G College Ballia, U.P. held on October15 -17, 2005.
38. Dutta S., Patel G.K., Khedmatgozar H., Latour D., Welsh J., Latour D., Tripathi M., Nandana S. (2024) A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers enzalutamide resistance in prostate cancer. Cancer Research (2024) 84 (6_Supplement)6603. https://doi.org/10.1158/1538-7445.AM2024-6603
39. Khushman M., Abushukair H., Modekurty S., Patel G.K., Abdelrahim M., Abdullah E., Maun Baral M., Singh A.P. (2024) The association between different molecular alterations in Wnt/β-catenin signaling and response to treatment with immune checkpoint inhibitors in solid tumors. Journal for ImmunoTherapy of Cancer (JITC) Abstract ID: 7985 submitted in SITC 39th Annual Meeting & Pre-Conference Programs, November 6 - 10, 2024 in Houston, TX, USA.